BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17409452)

  • 1. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
    Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of estrogen receptors alpha and beta in human breast carcinoma by exogenous leptin in nude mouse xenograft model.
    Yu W; Gu JC; Liu JZ; Wang SH; Wang Y; Zhang ZT; Ma XM; Song MM
    Chin Med J (Engl); 2010 Feb; 123(3):337-43. PubMed ID: 20193256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
    Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
    Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol.
    Xu P; Ye W; Jen R; Lin SH; Kuo CT; Lin YC
    Anticancer Res; 2009 Nov; 29(11):4621-8. PubMed ID: 20032412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
    Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
    Zhang TF; Yu SQ; Wang ZY
    Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin-dependent intercellular adhesion enhances chemoresistance.
    Nakamura T; Kato Y; Fuji H; Horiuchi T; Chiba Y; Tanaka K
    Int J Mol Med; 2003 Nov; 12(5):693-700. PubMed ID: 14532995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus.
    Malaguti C; Rossini GP
    J Cell Physiol; 2002 Aug; 192(2):171-81. PubMed ID: 12115723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS; Ino Y; Sakamoto M; Hirohashi S
    Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
    Tomlinson JS; Alpaugh ML; Barsky SH
    Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
    Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
    Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol "in situ" production.
    Catalano S; Rizza P; Gu G; Barone I; Giordano C; Marsico S; Casaburi I; Middea E; Lanzino M; Pellegrino M; Andò S
    J Cell Physiol; 2007 May; 211(2):448-56. PubMed ID: 17167783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin.
    Toyoshima M; Tanaka N; Aoki J; Tanaka Y; Murata K; Kyuuma M; Kobayashi H; Ishii N; Yaegashi N; Sugamura K
    Cancer Res; 2007 Jun; 67(11):5162-71. PubMed ID: 17545595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.